Osiris Therapeutics (OSIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,541 | 1,377 | -246 | -1,325 | -2,039 |
| Depreciation Amortization | 547 | 267 | 940 | 685 | 441 |
| Accounts receivable | -14,291 | -7,715 | -16,848 | -13,987 | -9,431 |
| Other Working Capital | -12,171 | -2,874 | -22,552 | -16,852 | -10,055 |
| Other Operating Activity | 22,470 | 8,586 | 35,557 | 16,831 | 11,072 |
| Operating Cash Flow | $-904 | $-359 | $-3,149 | $-14,648 | $-10,012 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -17 | 1,829 | 2,182 | -2,646 | -5,810 |
| PPE Investments | -537 | -345 | -1,131 | -801 | -440 |
| Net Acquisitions | N/A | N/A | N/A | 15,000 | 15,000 |
| Investing Cash Flow | $-554 | $1,484 | $1,051 | $11,553 | $8,750 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -22 | -11 | -45 | -34 | -22 |
| Common Stock Issued | 716 | 328 | 1,685 | 1,441 | 1,417 |
| Other Financing Activity | 119 | 54 | 250 | 218 | 109 |
| Financing Cash Flow | $813 | $371 | $1,890 | $1,625 | $1,504 |
| Beginning Cash Position | 2,208 | 2,208 | 2,416 | 2,416 | 2,416 |
| End Cash Position | 1,563 | 3,704 | 2,208 | 946 | 2,658 |
| Net Cash Flow | $-645 | $1,496 | $-208 | $-1,470 | $242 |
| Free Cash Flow | |||||
| Operating Cash Flow | -904 | -359 | -3,149 | -14,648 | -10,012 |
| Capital Expenditure | -537 | -345 | -1,131 | -801 | -440 |
| Free Cash Flow | -1,441 | -704 | -4,280 | -15,449 | -10,452 |